Medicine. Microbicide shuts the door on HIV.
Jon
J
Cohen
D000282:Administration, Intravaginal; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D065100:CCR5 Receptor Antagonists; D018946:Chemokine CCL5 / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D000882:Haplorhini; D006801:Humans; D008297:Male; D019713:Receptors, CCR5 / Q000378:metabolism; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control* / Q000635:transmission; D015302:Simian Immunodeficiency Virus / Q000187:drug effects; D014621:Vagina / Q000821:virology
D019380:Anti-HIV Agents; D000891:Anti-Infective Agents, Local; D065100:CCR5 Receptor Antagonists; D018946:Chemokine CCL5; C492865:RANTES, N(alpha)-(n-nonanoyl)-desSer(1)-(thioproline(2),cyclohexylglycine(3))-; D019713:Receptors, CCR5